Acute Myeloid Leukemia with Mllt3-mll

• CLINICAL_TRIALS trial_result · 2021-09-09
  Clinical Trial Update: Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement [Phase 1, Phase 2]

  Phase 1/2 trial evaluating pinometostat and azacitidine in patients with 11q23/MLL rearranged AML across relapsed, refractory, or newly diag…

• CLINICAL_TRIALS trial_result · 2015-08-20
  Clinical Trial Update: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia [Phase 1]

  A Phase 1 study evaluating a combination of azacitidine, mitoxantrone hydrochloride, and etoposide in older patients with poor-prognosis acu…

• CLINICAL_TRIALS trial_result · 2014-12-23
  Clinical Trial Update: Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Phase 1]

  Phase 1 clinical trial evaluating a combination of lenalidomide, cytarabine, and idarubicin in adults with acute myeloid leukemia; the study…